Ligand News and Research

RSS
Primary cilium's GPS-like cell structure crucial to wound repair

Primary cilium's GPS-like cell structure crucial to wound repair

Researchers create tiny, implantable device that captures and kills cancer cells in the bloodstream

Researchers create tiny, implantable device that captures and kills cancer cells in the bloodstream

Osmium as a cancer treatment

Osmium as a cancer treatment

EpiVax receives grant for $390,000 to optimize HIV vaccine delivery

EpiVax receives grant for $390,000 to optimize HIV vaccine delivery

FDA approves GSK's Promacta (Eltrombopag)

FDA approves GSK's Promacta (Eltrombopag)

Phosphaplatins kill ovarian, testicular, head and neck cancer cells

Phosphaplatins kill ovarian, testicular, head and neck cancer cells

Scientists discover a catalytic antibody that degrades a known appetite stimulant

Scientists discover a catalytic antibody that degrades a known appetite stimulant

Corgenix receives third U.S. patent on AtherOx technology

Corgenix receives third U.S. patent on AtherOx technology

Cannabinoid cell surface receptor plays a tumor-suppressing role in human colorectal cancer

Cannabinoid cell surface receptor plays a tumor-suppressing role in human colorectal cancer

Amgen announces positive results for Denosumab postmenopausal osteoporosis trial

Amgen announces positive results for Denosumab postmenopausal osteoporosis trial

HIV-I damages the immune system early than originally thought

HIV-I damages the immune system early than originally thought

Sale of liver disease therapeutic patents

Sale of liver disease therapeutic patents

Holey nanoparticles create new tumor imaging and therapeutic agent

Holey nanoparticles create new tumor imaging and therapeutic agent

Improving quantum dot synthesis

Improving quantum dot synthesis

Targeted therapy combo overcomes treatment resistance in liver cancer

Targeted therapy combo overcomes treatment resistance in liver cancer

Targeted therapies overcome treatment resistance in liver cancer cell lines

Targeted therapies overcome treatment resistance in liver cancer cell lines

XYNTHA approved for teatment of hemophilia A by FDA

XYNTHA approved for teatment of hemophilia A by FDA

Gene therapy - immune system discovery may lead to effective treatment for glioblastoma multiforme

Gene therapy - immune system discovery may lead to effective treatment for glioblastoma multiforme

Major milestone in the culturing of human blood stem cells

Major milestone in the culturing of human blood stem cells

Gene therapy protocol at UCSD activates immune system in patients with leukemia

Gene therapy protocol at UCSD activates immune system in patients with leukemia